Rhabdomyolysis and renal injury with lovastatin use. Report of two cases in cardiac transplant recipients.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  JAMA

• Publication date

  1988-07-08

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/JAMA.1988.03410020105038
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Hyperlipidemia following heart transplantation: natural history and intervention with mevinolin (lovastatin).

  1987cited by this paper
• Influence of erythromycin on cyclosporine pharmacokinetics.

  1987cited by this paper
• Cyclosporine: a new immunosuppressive agent for organ transplantation.

  1984cited by this paper
• Accelerated atherosclerosis in cardiac transplantation: role of cytotoxic B-cell antibodies and hyperlipidemia.

  1983cited by this paper
• Cholesterol-lowering effect of mevinolin, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme a reductase, in healthy volunteers.

  1982cited by this paper
• Rapid and substantial lowering of human serum cholesterol by mevinolin (MK-803), an inhibitor of hydroxymethylglutaryl-coenzyme A reductase.

  1982cited by this paper
• Legionnaires' Disease: Report of Sixty‐five Nosocomially Acquired Cases and Review of the Literature

  1980cited by this paper
• Case 17-1978: Acute Renal Failure and Hemoptysis in a 44-Year-Old Man

  1978cited by this paper
• Legionnaires' disease in non-Legionnaires. A report of five cases.

  1978cited by this paper
• Studies on the pathogenesis of atheroarteriosclerosis induced in rabbit cardiac allografts by the synergy of graft rejection and hypercholesterolemia.

  1977cited by this paper

• Are Muscular Dystrophies Cholesterol‐Handling Diseases? Lessons From HMGCR Variants and Statin‐Associated Myopathies

  2026cites this paper
• Towards streamlined product information: reporting of transporter-mediated drug interactions

  2024cites this paper
• Modeling the effects of commonly used drugs on human metabolism

  2015cites this paper
• Risk identification and possible countermeasures for muscle adverse effects during statin therapy.

  2015cites this paper
• Graft Vessel Disease Following Heart Transplantation: A Systematic Review of the Role of Statin Therapy

  2014cites this paper
• Red mold dioscorea: a potentially safe traditional function food for the treatment of hyperlipidemia.

  2012cites this paper
• Clinical response to statins: Mechanism(s) of variable activity and adverse effects

  2012cites this paper
• Pharmacokinetic comparison of controlled-release and immediate-release oral formulations of simvastatin in healthy Korean subjects: a randomized, open-label, parallel-group, single- and multiple-dose study.

  2010cites this paper
• INFLAMMATORY BOWEL DISEASES

  2009cites this paper
• Statin Adverse Effects

  2008cites this paper
• Pharmacokinetic consequences of time-dependent inhibition using the isolated perfused rat liver model

  2006cites this paper
• Muscular Side Effects of Statins

  2002cites this paper
• The role of cytochrome P450-mediated drug-drug interactions in determining the safety of statins

  2001cites this paper
• Long-term safety of hepatic hydroxymethyl glutaryl coenzyme A reductase inhibitors: the role of metabolism-monograph for physicians.

  2000cites this paper
• Treatment of hyperlipidemia.

  2000cites this paper
• Rhabdomyolysis and Acute Renal Failure in a Cardiac Transplant Recipient due to Multiple Drug Interactions

  1999cites this paper
• Long‐Term safety of pravastatin‐gemfibrozil therapy in mixed hyperlipidemia

  1999cites this paper
• Update: Clinically Significant Cytochrome P‐450 Drug Interactions

  1998cites this paper
• Long-term safety of statin-fibrate combination treatment in the management of hypercholesterolaemia in patients with coronary artery disease.

  1995cites this paper
• Post‐transplant hyperlipidemia: Risk factors and response to dietary modification and gemfibrozil therapy

  1995cites this paper
• Comparative Evaluation of the Safety and Efficacy of HMG-CoA Reductase Inhibitor Monotherapy in the Treatment of Primary Hypercholesterolemia

  1995cites this paper
• Simvastatin. A reappraisal of its pharmacology and therapeutic efficacy in hypercholesterolaemia.

  1995cites this paper
• Electrical myotonia of rabbit skeletal muscles by HMG‐CoA reductase inhibitors

  1994cites this paper
• Transplantation and the problems afterward including coronary vasculopathy

  1994cites this paper
• The influence of pretransplant lipoprotein abnormalities on the early results of renal transplantation

  1993cites this paper
• The further of paediatric cardiology in the United Kingdom

  1993cites this paper
• Rhabdomyolysis due to combined treatment with lovastatin and cholestyramine.

  1992cites this paper
• A Retrospective Review of the Use of Lipid‐Lowering Agents in Combination, Specifically, Gemfibrozil and Lovastatin

  1992cites this paper
• Endocrine and metabolic abnormalities following kidney transplantation

  1989cites this paper